Posts
Pfizer said it has stopped a
late-stage study of its drug Lyrica as a potential treatment for HIV-related
nerve pain. In the United States, Lyrica already is approved to treat nerve
pain from diabetes, pain following shingles, fibromyalgia, and some seizures in
adults with epilepsy.
Pfizer has been studying Lyrica’s
potential use for HIV neuropathy, a condition involving nerve damage marked by
burning pain that typically begins in the feet. However, an early analysis of
study data found that pain improvements in treated patients were almost
identical to those who received a placebo. The study did not raise any safety
concerns; Pfizer plans further analysis of the results.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!
